{"id":538,"date":"2026-05-19T09:31:00","date_gmt":"2026-05-19T13:31:00","guid":{"rendered":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/?p=538"},"modified":"2026-05-19T09:31:01","modified_gmt":"2026-05-19T13:31:01","slug":"highlights-from-the-food-drug-law-institutes-annual-conference-2026","status":"publish","type":"post","link":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2026\/05\/19\/highlights-from-the-food-drug-law-institutes-annual-conference-2026\/","title":{"rendered":"Highlights from the Food &amp; Drug Law Institute&#8217;s Annual Conference 2026"},"content":{"rendered":"\n<p>By <a href=\"https:\/\/www.duanemorris.com\/attorneys\/frederickrball.html\">Frederick R. Ball<\/a> and\u00a0<a href=\"https:\/\/www.duanemorris.com\/attorneys\/victoriahawekotte.html\">Victoria (Tori) Hawekotte<\/a><\/p>\n\n\n\n<p>Attorneys from Duane Morris\u2019 <a href=\"https:\/\/www.duanemorris.com\/practices\/life_sciences_medical_technologies.html\">Life Sciences and Medical Technologies Industry Group<\/a> attended the Food &amp; Drug Law Institute\u2019s Annual Conference, which featured participation from senior leadership at the Food and Drug Administration. Former FDA Commissioner Martin Makary highlighted the agency\u2019s aim to decrease time to decision on applications and increase efficiency of reviews. He also discussed the trend of research and manufacturing moving internationally and potential reforms to make domestic manufacturing and research more feasible.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.duanemorris.com\/alerts\/highlights_food_drug_law_institute_conference_2026_0526.html\">Read the full <em>Alert<\/em> on the Duane Morris LLP website<\/a>.<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>By Frederick R. Ball and\u00a0Victoria (Tori) Hawekotte Attorneys from Duane Morris\u2019 Life Sciences and Medical Technologies Industry Group attended the Food &amp; Drug Law Institute\u2019s Annual Conference, which featured participation from senior leadership at the Food and Drug Administration. Former FDA Commissioner Martin Makary highlighted the agency\u2019s aim to decrease time to decision on applications &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2026\/05\/19\/highlights-from-the-food-drug-law-institutes-annual-conference-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Highlights from the Food &amp; Drug Law Institute&#8217;s Annual Conference 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[29,731,209,221],"ppma_author":[521],"class_list":["post-538","post","type-post","status-publish","format-standard","hentry","category-general","tag-fda","tag-food-and-drug-law","tag-frederick-ball","tag-life-sciences"],"authors":[{"term_id":521,"user_id":6,"is_guest":0,"slug":"duanemorris3","display_name":"Duane Morris","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/843ff6e7a8fe5fc92109b47a45f34b6cf0ea499e6e788db23456c838b0ae6747?s=96&d=blank&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/comments?post=538"}],"version-history":[{"count":0,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/538\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/media?parent=538"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/categories?post=538"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/tags?post=538"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/ppma_author?post=538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}